|
|
Volumn 3, Issue 2, 2001, Pages 165-169
|
|
Recent developments in weekly paclitaxel therapy in lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PACLITAXEL;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
HUMAN;
LUNG TUMOR;
PROGNOSIS;
RADIATION DOSE FRACTIONATION;
REVIEW;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CLINICAL TRIALS;
DOSE FRACTIONATION;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
PROGNOSIS;
|
|
EID: 0035290985
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0017-4 Document Type: Review |
|
Times cited : (4)
|
|
References (25)
|
